{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:10:47Z","timestamp":1784776247729,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.mayocp.2023.05.005","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T19:23:38Z","timestamp":1688066618000},"page":"249-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Progression to Insulin Therapy in Patients With Type 2 Diabetes According to Cardiorespiratory Fitness, Body Mass Index, and Statin Therapy"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6055-7634","authenticated-orcid":false,"given":"Peter","family":"Kokkinos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Nylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Faselis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pittaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immanuel Babu Henry","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3906-1911","authenticated-orcid":false,"given":"Carl","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Doumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Heimall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6360-386X","authenticated-orcid":false,"given":"Rayelynn","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2023.05.005_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2020.7848","article-title":"Association of statin use with all-cause and cardiovascular mortality in US veterans 75 years and older","volume":"324","author":"Orkaby","year":"2020","journal-title":"JAMA"},{"issue":"9864","key":"10.1016\/j.mayocp.2023.05.005_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0140-6736(12)61426-3","article-title":"Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study","volume":"381","author":"Kokkinos","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mayocp.2023.05.005_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacc.2007.02.073","article-title":"Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials","volume":"50","author":"Alsheikh-Ali","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.mayocp.2023.05.005_bib4","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2023.05.005_bib5","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.2337\/dc23-S010","article-title":"10. Cardiovascular disease and risk management: Standards of Care in Diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.mayocp.2023.05.005_bib6","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.mayocp.2023.05.005_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.numecd.2017.03.001","article-title":"Statin use and risk of new-onset diabetes: a meta-analysis of observational studies","volume":"27","author":"Casula","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2023.05.005_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12933-020-01037-0","article-title":"Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study","volume":"19","author":"Na","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.mayocp.2023.05.005_bib9","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.10.053","article-title":"Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients","volume":"55","author":"Koh","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mayocp.2023.05.005_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1758-5996-6-53","article-title":"Statins use is associated with poorer glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes","volume":"6","author":"Liew","year":"2014","journal-title":"Diabetol Metab Syndr"},{"issue":"12","key":"10.1016\/j.mayocp.2023.05.005_bib11","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/jamainternmed.2021.5714","article-title":"Association of statin therapy initiation with diabetes progression: a retrospective matched-cohort study","volume":"181","author":"Mansi","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"25","key":"10.1016\/j.mayocp.2023.05.005_bib12","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mayocp.2023.05.005_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.mayocp.2023.05.005_bib14","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1210\/jc.2013-1431","article-title":"Statins modulate the mortality risk associated with obesity and cardiorespiratory fitness in diabetics","volume":"98","author":"Nylen","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.mayocp.2023.05.005_bib15","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.amjmed.2017.04.042","article-title":"Cardiorespiratory fitness and incidence of type 2 diabetes in United States veterans on statin therapy","volume":"130","author":"Kokkinos","year":"2017","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2023.05.005_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.32086","article-title":"Comparison of all-cause mortality rates and inequities between black and white populations across the 30 most populous US cities","volume":"4","author":"Benjamins","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.mayocp.2023.05.005_bib17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1056\/NEJM199609123351106","article-title":"Effects of race and income on mortality and use of services among Medicare beneficiaries","volume":"335","author":"Gornick","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"6 suppl 1","key":"10.1016\/j.mayocp.2023.05.005_bib18","first-page":"I7","article-title":"Reinventing VA health care: systematizing quality improvement and quality innovation","volume":"38","author":"Kizer","year":"2000","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.mayocp.2023.05.005_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00005650-200203000-00007","article-title":"Risk-adjusted mortality rates as a potential outcome indicator for outpatient quality assessments","volume":"40","author":"Selim","year":"2002","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.mayocp.2023.05.005_bib20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jacc.2022.05.031","article-title":"Cardiorespiratory fitness and mortality risk across the spectra of age, race, and sex","volume":"80","author":"Kokkinos","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.mayocp.2023.05.005_bib21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/pds.3921","article-title":"Validation of methods for assessing cardiovascular disease using electronic health data in a cohort of Veterans with diabetes","volume":"25","author":"Floyd","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"10.1016\/j.mayocp.2023.05.005_bib22","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.mayocp.2023.05.005_bib23","series-title":"ACSM's Guidelines for Exercise Testing and Prescription","year":"2018"},{"issue":"3","key":"10.1016\/j.mayocp.2023.05.005_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.mayocp.2017.10.011","article-title":"Cardiorespiratory fitness and health outcomes: a call to standardize fitness categories","volume":"93","author":"Kokkinos","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.mayocp.2023.05.005_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.103.3.357","article-title":"Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study","volume":"103","author":"Freeman","year":"2001","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.mayocp.2023.05.005_bib26","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jand.2015.02.031","article-title":"Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials","volume":"115","author":"Franz","year":"2015","journal-title":"J\u00a0Acad Nutr Diet"},{"issue":"9","key":"10.1016\/j.mayocp.2023.05.005_bib27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/M18-0222","article-title":"Cardiovascular disease and risk management: review of the American Diabetes Association Standards of Medical Care in Diabetes 2018","volume":"168","author":"Chamberlain","year":"2018","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.mayocp.2023.05.005_bib28","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCULATIONAHA.107.185650","article-title":"Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association","volume":"116","author":"Nelson","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mayocp.2023.05.005_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsem-2016-000143","article-title":"Update on the effects of physical activity on insulin sensitivity in humans","volume":"2","author":"Bird","year":"2017","journal-title":"BMJ Open Sport Exerc Med"},{"issue":"8","key":"10.1016\/j.mayocp.2023.05.005_bib30","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.110.938852","article-title":"Exercise capacity and mortality in older men: a 20-year follow-up study","volume":"122","author":"Kokkinos","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mayocp.2023.05.005_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41576-021-00400-5","article-title":"The genetics of human performance","volume":"23","author":"Kim","year":"2022","journal-title":"Nat Rev Genet"},{"issue":"2","key":"10.1016\/j.mayocp.2023.05.005_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc21-1815","article-title":"Utilization rates of SGLT2 inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type 2 diabetes: insights from the Department of Veterans Affairs","volume":"45","author":"Mahtta","year":"2022","journal-title":"Diabetes Care"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962300201X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962300201X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T22:20:38Z","timestamp":1706826038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561962300201X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S002561962300201X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.05.005","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progression to Insulin Therapy in Patients With Type 2 Diabetes According to Cardiorespiratory Fitness, Body Mass Index, and Statin Therapy","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}